About ALNY

Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is leading the translation of RNAi as a new class of innovative medicines. Alnylams pipeline of investigational RNAi therapeutics is focused in 3 Strategic Therapeutic Areas (STArs): Genetic Medicines, with a broad pipeline of RNAi therapeutics for the treatment of rare diseases; Cardio-Metabolic Disease, with a pipeline of RNAi therapeutics toward genetically validated, liver-expressed disease targets for unmet needs in cardiovascular and metabolic diseases; and Hepatic Infectious Disease, with a pipeline of RNAi therapeutics that address the major global health challenges of hepatic infectious diseases. In early 2015, Alnylam launched its Alnylam 2020 guidance for the advancement and commercialization of RNAi therapeutics as a whole new class of innovative medicines. Specifically, by the end of 2020, Alnylam expects to achieve a company profile with 3 marketed products, 10 RNAi therapeutic clinical programs including 4 in late stages of development across its 3 STArs. The companys demonstrated commitment to RNAi therapeutics has enabled it to form major alliances with leading companies including Merck, Medtronic, Novartis, Biogen, Roche, Takeda, Kyowa Hakko Kirin, Cubist, GlaxoSmithKline, Ascletis, Monsanto, The Medicines Company, and Genzyme, a Sanofi company. In addition, Alnylam holds an equity position in Regulus Therapeutics Inc., a company focused on discovery, development, and commercialization of microRNA therapeutics. Founded in 2002, Alnylam maintains headquarters in Cambridge, Massachusetts. www.alnylam.com.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ALNY is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
EQAL Invesco Russell 1000 Equal Weight ETF 556.8 M 5.568E+08 961 961 0.09% 0.0009 510 K 510202
EQWM Invesco Russell Midcap Equal Weight ETF 24.0 M 2.4E+07 768 768 0.13% 0.00133 32 K 32413
PBE Invesco Dynamic Biotech & Genome ETF 230.3 M 2.303E+08 30 30 4.72% 0.04721 11.0 M 1.10158E+07
PRFZ Invesco FTSE RAFI US 1500 Small-Mid ETF 2.0 B 1.9571E+09 1,485 1485 0.07% 0.00071 1.4 M 1416350
TILT FlexShares Mornigstar US Market Factors Tilt Index Fund ETF 1.4 B 1.40497E+09 1,988 1988 0.02% 0.000197 272 K 271640
FBT First Trust Amex Biotech Index Fund 2.8 B 2.7602E+09 30 30 2.82% 0.0282 77.8 M 7.783763E+07
BBH VanEck Vectors Biotech ETF 372.0 M 3.72E+08 25 25 2.22% 0.0222 8.2 M 8241220
EUSA iShares MSCI USA Equal Weighted ETF 261.4 M 2.61416E+08 623 623 0.13% 0.0013 347 K 346984
IBB iShares Nasdaq Biotechnology Index Fund 7.3 B 7.34933E+09 222 222 1.0% 0.01 73.9 M 7.39025E+07
ITOT iShares Core S&P Total U.S. Stock Market ETF 19.5 B 1.95299E+10 3,547 3547 0.02% 0.0002 4.4 M 4444540
IWB iShares Russell 1000 ETF 19.4 B 1.93522E+10 975 975 0.02% 0.0002 4.7 M 4658750
IWD iShares Russell 1000 Value ETF 37.5 B 3.75232E+10 719 719 0.01% 0.0001 2.3 M 2263290
IWF iShares Russell 1000 Growth ETF 42.6 B 4.25965E+10 544 544 0.04% 0.0004 18.1 M 1.80826E+07
IWP iShares Russell Midcap Growth ETF 10.4 B 1.042E+10 416 416 0.18% 0.0018 19.0 M 1.89996E+07
IWR iShares Russell Mid-Cap ETF 18.5 B 1.85011E+10 780 780 0.09% 0.0009 16.2 M 1.62309E+07
IWS iShares Russell Mid-cap Value ETF 10.6 B 1.05873E+10 586 586 0.02% 0.0002 1.9 M 1866200
IWV iShares Russell 3000 ETF 9.1 B 9.10141E+09 2,929 2929 0.02% 0.0002 2.1 M 2054910
IYH iShares U.S. Healthcare ETF 2.0 B 2.0448E+09 129 129 0.18% 0.0018 3.6 M 3642350
IYY iShares Dow Jones U.S. ETF 1.2 B 1.18267E+09 1,222 1222 0.02% 0.0002 279 K 278631
JKH iShares Morningstar Mid-Cap Growth ETF 496.8 M 4.96753E+08 197 197 0.31% 0.0031 1.6 M 1574750
SIZE iShares Edge MSCI USA Size Factor ETF 387.7 M 3.87664E+08 623 623 0.15% 0.0015 576 K 575504
LABU Direxion Daily S&P Biotech Bull 3X Shares 621.3 M 6.21347E+08 131 131 0.27% 0.00271218 5.9 M 5861240
FHLC Fidelity MSCI Health Care Index ETF 1.5 B 1.5E+09 356 356 0.16% 0.00156304 2.4 M 2376740
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 2.1 B 2.1E+09 1,002 1002 0.06% 0.000579179 1.2 M 1217380
BIB ProShares Ultra Nasdaq Biotechnology 223.8 M 2.2382E+08 239 239 0.44% 0.00439958 2.1 M 2062090
RXL ProShares Ultra Health Care 104.5 M 1.04533E+08 145 145 0.08% 0.000751003 167 K 166651
UBIO Proshares UltraPro Nasdaq Biotechnology 28.3 M 2.82606E+07 228 228 0.29% 0.00290477 255 K 255477